- Lobbying
- merck
Lobbying Arrangements Results for 'Merck'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to FDA product approval. |
EMD Serono, Inc.
|
Crossroads Strategies, LLC | |||
Details Affordable Prescriptions for Patients Act of 2019, S.1416; issues related to patents on biopharmaceutical products; Terminating the Extension of Rights Misappropriated Act of 2019, H.R. 3199; Affor... |
MERCK & CO, Inc
|
Akin, Gump, Strauss, Hauer & Feld | |||
Details Issues regarding the availability and pricing of prescription drugs. |
EMD Serono, Inc.
|
Capitol Counsel, LLC | |||
Details Discussions related to industrial base expansion programs regarding biomanufacturing |
EMD Millipore Corporation
|
in-house lobbying | |||
Details Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage. Issues related to drug pricing. Package Inserts/E-Labeling Issues (H.R. 1503 Prescription... |
Merck & Company, Inc.
|
Capitol Counsel LLC | |||
Details Assistance to resolve a customs issue in the Philippines |
MERCK & CO, INC
|
COVINGTON & BURLING LLP | |||
Details Medicare reimbursement issues, FDA regulation of biosimilars. |
The Biosimilars Forum
|
HOLLAND & KNIGHT LLP | |||
Details Pharmaceutical distribution and supply chain security. |
Pharmaceutical Distribution Security Alliance (PDSA)
|
Leavitt Partners, LLC | |||
Details Issues impacting the life sciences industry, including testing manufacturing, vaccines, supply chain reforms, and pandemic preparedness. Issues related to Section 301 tariffs; Issues related to sup... |
EMD Millipore
|
Tiber Creek Group | |||
Details Sepsis education and awareness; incentives for prevention, diagnosis and treatment of sepsis; H.Res.290 - Supporting Increased Awareness of Sepsis and the Importance of Early Diagnosis and Appropri... |
Sepsis Stakeholder Coalition
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916,... |
Merck & Co, Inc.
|
in-house lobbying | |||
Details Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare, Medicaid and generally, including proposed reform proposals. Issues relating to trade agreem... |
MERCK & CO., INC
|
Capitol Hill Strategies, LLC | |||
Details Industrial Base Expansion. Pharmaceutical Manufacturing and Supply Chain. |
EMD Millipore
Biochemicals and reagents for life science research and discovery. |
Todd Strategy Group | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, T... |
Merck & Co., Inc.
|
Crossroads Strategies, LLC | |||
Details Drug pricing policy. Implementation of Inflation Reduction Act of 2022. HELP Copays Act. PROTECT Act. PBM Reform. 340B Program. Supply chain. Advanced Research Projects Agency for Health funding is... |
EMD Serono Inc.
|
Todd Strategy Group | |||
Details Drug pricing proposals. Pharmacy Benefit Manager reform proposals. Tax policy impacting health care and pharmaceutical industry. |
MERCK & CO, INC
|
Williams and Jensen, PLLC | |||
Details Federal budget issues H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars IRA implementation, Me... |
Merck
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details Tax issues: comprehensive tax reform, deferral and transfer pricing. Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11). Base erosion. Budget issues, including Medicare Par... |
MERCK AND CO., INC.
|
MEHLMAN VOGEL CASTAGNETTI, INC. | |||
Details Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 951... |
Alliance for Biopharmaceutical Competitiveness and Innovation
|
The Washington Tax & Public Policy Group (formerly The Washington Tax Group) | |||
Details General education about women's access to healthcare benefits under the federal law; issues related to opioid addiction. Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 60... |
Women's Health Coalition
|
Williams and Jensen, PLLC | |||
Details Provide tax legislative and strategic advisory services with respect to legislative proposals to impose higher taxes on income from intangibles. |
Working Group on Intangibles (Informal Coalition)
|
Ernst & Young LLP (Washington Council Ernst & Young) |